Lalwani Nikhil 4
4 · ANI PHARMACEUTICALS INC · Filed May 16, 2024
Insider Transaction Report
Form 4
Lalwani Nikhil
DirectorPRESIDENT & CEO
Transactions
- Sale
Common Stock
[F1]2024-05-14$66.10/sh−16,669$1,101,821→ 377,505 total
Footnotes (1)
- [F1]The shares were sold in multiple trades at prices ranging from $65.67 to $67.56. The price reported above reflects the weighted average sales price.
Signature
/s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook|2024-05-16